219 related articles for article (PubMed ID: 37888812)
1. How do Mutations of Mycobacterium Genes Cause Drug Resistance in Tuberculosis?
Hou K; Jabeen R; Sun L; Wei J
Curr Pharm Biotechnol; 2024; 25(6):724-736. PubMed ID: 37888812
[TBL] [Abstract][Full Text] [Related]
2. Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
Yenew B; Kebede A; Alemu A; Diriba G; Mehammed Z; Amare M; Dagne B; Sinshaw W; Tesfaye E; Beyene D; Abegaz WE
PLoS One; 2024; 19(5):e0303460. PubMed ID: 38753615
[TBL] [Abstract][Full Text] [Related]
3. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.
Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A
Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637
[TBL] [Abstract][Full Text] [Related]
4. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
[TBL] [Abstract][Full Text] [Related]
5. Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
Jabbar A; Phelan JE; de Sessions PF; Khan TA; Rahman H; Khan SN; Cantillon DM; Wildner LM; Ali S; Campino S; Waddell SJ; Clark TG
Sci Rep; 2019 Oct; 9(1):14996. PubMed ID: 31628383
[TBL] [Abstract][Full Text] [Related]
6. Genotype analysis of ofloxacin-resistant multidrug-resistant
Gupta A; Sinha P; Rathod S; Shanmugam SK; Uma Devi KR; Anupurba S; Nema V
Indian J Med Res; 2020 Apr; 151(4):361-370. PubMed ID: 32461400
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Mutations in Genes Related to Rifampicin and Isoniazid Resistance in Multidrug-resistant
Huang YY; Xie L; Wu YF; Jia QJ; Cheng QL; Li QC; Ai LY; Bai XX
Biomed Environ Sci; 2023 Sep; 36(9):869-873. PubMed ID: 37803899
[No Abstract] [Full Text] [Related]
8. Molecular characterization of mutations associated with resistance to second line drugs in Mycobacterium tuberculosis patients from Casablanca, Morocco.
Momen G; Aainouss A; Lamaammal A; Chettioui F; Blaghen M; Messoudi M; Belghmi K; Mouslim J; El Mzibri M; El Messaoudi MD; Khyatti M; Chaoui I
Rev Inst Med Trop Sao Paulo; 2021; 63():e19. PubMed ID: 33787739
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
10. Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.
Manson AL; Cohen KA; Abeel T; Desjardins CA; Armstrong DT; Barry CE; Brand J; ; Chapman SB; Cho SN; Gabrielian A; Gomez J; Jodals AM; Joloba M; Jureen P; Lee JS; Malinga L; Maiga M; Nordenberg D; Noroc E; Romancenco E; Salazar A; Ssengooba W; Velayati AA; Winglee K; Zalutskaya A; Via LE; Cassell GH; Dorman SE; Ellner J; Farnia P; Galagan JE; Rosenthal A; Crudu V; Homorodean D; Hsueh PR; Narayanan S; Pym AS; Skrahina A; Swaminathan S; Van der Walt M; Alland D; Bishai WR; Cohen T; Hoffner S; Birren BW; Earl AM
Nat Genet; 2017 Mar; 49(3):395-402. PubMed ID: 28092681
[TBL] [Abstract][Full Text] [Related]
11.
Jagadeb M; Rath SN; Sonawane A
J Biomol Struct Dyn; 2019 Aug; 37(13):3388-3398. PubMed ID: 30132739
[TBL] [Abstract][Full Text] [Related]
12. [Mycobacterium tuberculosis mutants with multidrug resistance: history of origin, genetic and molecular mechanisms of resistance, and emerging challenges].
Prozorov AA; Zaĭchikova MV; Danilenko VN
Genetika; 2012 Jan; 48(1):5-20. PubMed ID: 22567849
[TBL] [Abstract][Full Text] [Related]
13. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.
Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV
Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924
[TBL] [Abstract][Full Text] [Related]
14. Diversified lineages and drug-resistance profiles of clinical isolates of
Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal.
Poudel A; Nakajima C; Fukushima Y; Suzuki H; Pandey BD; Maharjan B; Suzuki Y
Antimicrob Agents Chemother; 2012 Jun; 56(6):2831-6. PubMed ID: 22450970
[TBL] [Abstract][Full Text] [Related]
16. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review.
Seifert M; Catanzaro D; Catanzaro A; Rodwell TC
PLoS One; 2015; 10(3):e0119628. PubMed ID: 25799046
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China.
Huang H; Ding N; Yang T; Li C; Jia X; Wang G; Zhong J; Zhang J; Jiang G; Wang S; Zong Z; Jing W; Zhao Y; Xu S; Chen F
Clin Infect Dis; 2019 Jul; 69(3):405-413. PubMed ID: 30321294
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
Al-Mutairi NM; Ahmad S; Mokaddas EM
Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis.
Post FA; Willcox PA; Mathema B; Steyn LM; Shean K; Ramaswamy SV; Graviss EA; Shashkina E; Kreiswirth BN; Kaplan G
J Infect Dis; 2004 Jul; 190(1):99-106. PubMed ID: 15195248
[TBL] [Abstract][Full Text] [Related]
20. Pyrazinamide Resistance among Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Myanmar.
Aung WW; Ei PW; Nyunt WW; Htwe MM; Win SM; Aye KT; Mon AS; Aung ST; Chang CL; Lee JS
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263056
[No Abstract] [Full Text] [Related]
[Next] [New Search]
